AnalyzeDirect

Tag Archives: Host MHC Class I expression

Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression

Zachariah P. Tritz et al. Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression Cancer Immunology Research. Publication Date March 15, 2023 How Analyze was Used “Volumes of the tumors were 129 determined using Analyze 12.0 software as 130 traced by a blinded reviewer on the transverse…